Biochemical diagnosis and assessment of disease activity in acromegaly

A two-decade experience

Francesco M. Minuto, Eugenia Resmini, Mara Boschetti, Alberto Rebora, Laura Fazzuoli, Marica Arvigo, Massimo Giusti, Diego Ferone

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The objective of this study is to assess the secretory pattern of GH after Oral Glucose Tolerance Test (OGTT) or day-curve (DC), in relation with IGF-I and to evaluate the influence of therapy on OGTT. A retrospective analysis in 279 OGTTs performed in 93 acromegalic patients in our unit from January 1988 to December 2005, in 77 patients also DC data were retrived. GH concentration was evaluated by 3 different systems (RIA, IRMA and chemiluminescence assays), and IGF-I by two RIAs. About 12% of OGTT samples were discordant with the baseline, while discordance between nadir and 120th minute was much lower (5%), with all discordant values, except one, near the cut-off lines. Correlation between DC and OGTT data was around 0.99 among all values, discordance rate between nadir and minimum DC was much lower than that with mean DC. In almost 80% of cases there was a complete concordance between OGTT and DC results, and in about 30% IGF-I was discordant with GH. Correlation analysis between IGF-I and GH was highest with DC data and lowest with OGTT baseline (T0). Considering different treatments discrepancy rates between GH and IGF-I were comparable. The best GH parameter is the minimum GH DC, although in the clinical practice the evaluation of OGTT GH in association with IGF-I is the most practical approach. In this case, the basal and T120 GH values can replace multiple sampling. Different treatment modalities do not influence the discordance rate between GH and IGF-I.

Original languageEnglish
Pages (from-to)215-221
Number of pages7
JournalPituitary
Volume15
Issue number2
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Acromegaly
Glucose Tolerance Test
Insulin-Like Growth Factor I
Luminescence
Therapeutics

Keywords

  • Acromegaly
  • Growth hormone
  • IGF-I
  • OGTT

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Minuto, F. M., Resmini, E., Boschetti, M., Rebora, A., Fazzuoli, L., Arvigo, M., ... Ferone, D. (2012). Biochemical diagnosis and assessment of disease activity in acromegaly: A two-decade experience. Pituitary, 15(2), 215-221. https://doi.org/10.1007/s11102-011-0313-4

Biochemical diagnosis and assessment of disease activity in acromegaly : A two-decade experience. / Minuto, Francesco M.; Resmini, Eugenia; Boschetti, Mara; Rebora, Alberto; Fazzuoli, Laura; Arvigo, Marica; Giusti, Massimo; Ferone, Diego.

In: Pituitary, Vol. 15, No. 2, 06.2012, p. 215-221.

Research output: Contribution to journalArticle

Minuto, FM, Resmini, E, Boschetti, M, Rebora, A, Fazzuoli, L, Arvigo, M, Giusti, M & Ferone, D 2012, 'Biochemical diagnosis and assessment of disease activity in acromegaly: A two-decade experience', Pituitary, vol. 15, no. 2, pp. 215-221. https://doi.org/10.1007/s11102-011-0313-4
Minuto FM, Resmini E, Boschetti M, Rebora A, Fazzuoli L, Arvigo M et al. Biochemical diagnosis and assessment of disease activity in acromegaly: A two-decade experience. Pituitary. 2012 Jun;15(2):215-221. https://doi.org/10.1007/s11102-011-0313-4
Minuto, Francesco M. ; Resmini, Eugenia ; Boschetti, Mara ; Rebora, Alberto ; Fazzuoli, Laura ; Arvigo, Marica ; Giusti, Massimo ; Ferone, Diego. / Biochemical diagnosis and assessment of disease activity in acromegaly : A two-decade experience. In: Pituitary. 2012 ; Vol. 15, No. 2. pp. 215-221.
@article{ea8bdab5cb894c76857d9cb3161c89fb,
title = "Biochemical diagnosis and assessment of disease activity in acromegaly: A two-decade experience",
abstract = "The objective of this study is to assess the secretory pattern of GH after Oral Glucose Tolerance Test (OGTT) or day-curve (DC), in relation with IGF-I and to evaluate the influence of therapy on OGTT. A retrospective analysis in 279 OGTTs performed in 93 acromegalic patients in our unit from January 1988 to December 2005, in 77 patients also DC data were retrived. GH concentration was evaluated by 3 different systems (RIA, IRMA and chemiluminescence assays), and IGF-I by two RIAs. About 12{\%} of OGTT samples were discordant with the baseline, while discordance between nadir and 120th minute was much lower (5{\%}), with all discordant values, except one, near the cut-off lines. Correlation between DC and OGTT data was around 0.99 among all values, discordance rate between nadir and minimum DC was much lower than that with mean DC. In almost 80{\%} of cases there was a complete concordance between OGTT and DC results, and in about 30{\%} IGF-I was discordant with GH. Correlation analysis between IGF-I and GH was highest with DC data and lowest with OGTT baseline (T0). Considering different treatments discrepancy rates between GH and IGF-I were comparable. The best GH parameter is the minimum GH DC, although in the clinical practice the evaluation of OGTT GH in association with IGF-I is the most practical approach. In this case, the basal and T120 GH values can replace multiple sampling. Different treatment modalities do not influence the discordance rate between GH and IGF-I.",
keywords = "Acromegaly, Growth hormone, IGF-I, OGTT",
author = "Minuto, {Francesco M.} and Eugenia Resmini and Mara Boschetti and Alberto Rebora and Laura Fazzuoli and Marica Arvigo and Massimo Giusti and Diego Ferone",
year = "2012",
month = "6",
doi = "10.1007/s11102-011-0313-4",
language = "English",
volume = "15",
pages = "215--221",
journal = "Pituitary",
issn = "1386-341X",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Biochemical diagnosis and assessment of disease activity in acromegaly

T2 - A two-decade experience

AU - Minuto, Francesco M.

AU - Resmini, Eugenia

AU - Boschetti, Mara

AU - Rebora, Alberto

AU - Fazzuoli, Laura

AU - Arvigo, Marica

AU - Giusti, Massimo

AU - Ferone, Diego

PY - 2012/6

Y1 - 2012/6

N2 - The objective of this study is to assess the secretory pattern of GH after Oral Glucose Tolerance Test (OGTT) or day-curve (DC), in relation with IGF-I and to evaluate the influence of therapy on OGTT. A retrospective analysis in 279 OGTTs performed in 93 acromegalic patients in our unit from January 1988 to December 2005, in 77 patients also DC data were retrived. GH concentration was evaluated by 3 different systems (RIA, IRMA and chemiluminescence assays), and IGF-I by two RIAs. About 12% of OGTT samples were discordant with the baseline, while discordance between nadir and 120th minute was much lower (5%), with all discordant values, except one, near the cut-off lines. Correlation between DC and OGTT data was around 0.99 among all values, discordance rate between nadir and minimum DC was much lower than that with mean DC. In almost 80% of cases there was a complete concordance between OGTT and DC results, and in about 30% IGF-I was discordant with GH. Correlation analysis between IGF-I and GH was highest with DC data and lowest with OGTT baseline (T0). Considering different treatments discrepancy rates between GH and IGF-I were comparable. The best GH parameter is the minimum GH DC, although in the clinical practice the evaluation of OGTT GH in association with IGF-I is the most practical approach. In this case, the basal and T120 GH values can replace multiple sampling. Different treatment modalities do not influence the discordance rate between GH and IGF-I.

AB - The objective of this study is to assess the secretory pattern of GH after Oral Glucose Tolerance Test (OGTT) or day-curve (DC), in relation with IGF-I and to evaluate the influence of therapy on OGTT. A retrospective analysis in 279 OGTTs performed in 93 acromegalic patients in our unit from January 1988 to December 2005, in 77 patients also DC data were retrived. GH concentration was evaluated by 3 different systems (RIA, IRMA and chemiluminescence assays), and IGF-I by two RIAs. About 12% of OGTT samples were discordant with the baseline, while discordance between nadir and 120th minute was much lower (5%), with all discordant values, except one, near the cut-off lines. Correlation between DC and OGTT data was around 0.99 among all values, discordance rate between nadir and minimum DC was much lower than that with mean DC. In almost 80% of cases there was a complete concordance between OGTT and DC results, and in about 30% IGF-I was discordant with GH. Correlation analysis between IGF-I and GH was highest with DC data and lowest with OGTT baseline (T0). Considering different treatments discrepancy rates between GH and IGF-I were comparable. The best GH parameter is the minimum GH DC, although in the clinical practice the evaluation of OGTT GH in association with IGF-I is the most practical approach. In this case, the basal and T120 GH values can replace multiple sampling. Different treatment modalities do not influence the discordance rate between GH and IGF-I.

KW - Acromegaly

KW - Growth hormone

KW - IGF-I

KW - OGTT

UR - http://www.scopus.com/inward/record.url?scp=84861455879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861455879&partnerID=8YFLogxK

U2 - 10.1007/s11102-011-0313-4

DO - 10.1007/s11102-011-0313-4

M3 - Article

VL - 15

SP - 215

EP - 221

JO - Pituitary

JF - Pituitary

SN - 1386-341X

IS - 2

ER -